Met5-enkephalin protects isolated adult rabbit cardiomyocytes via δ- opioid receptors

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 6 46-6, 1999, Pages

  Takasaki, Yasushi ^a   Wolff, Roger A ^b   Chien, Grace L ^a,b   Van Winkle, Donna M ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Cell viability; Heart; Hypoxia; Opioid peptides

Indexed keywords

BETA ENDORPHIN; DELTA OPIATE RECEPTOR; ENKEPHALIN; METENKEPHALIN; NALTRINDOLE; DRUG DERIVATIVE; ENKEPHALIN MET, ARG(6) PHE(7); ENKEPHALIN-MET, ARG(6)-PHE(7)-; LEUCINE ENKEPHALIN; MORPHINE; NALOXONE;

ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR FUNCTION; CELL DEATH; CELL VIABILITY; HEART MUSCLE CELL; HEART PROTECTION; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; RABBIT; RAT; RECEPTOR BINDING; REOXYGENATION; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; CELL HYPOXIA; CYTOLOGY; DRUG EFFECT; HEART; HEART MUSCLE; HEART MUSCLE ISCHEMIA; ISCHEMIC PRECONDITIONING; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BETA-ENDORPHIN; CELL HYPOXIA; CELLS, CULTURED; ENKEPHALIN, LEUCINE; ENKEPHALIN, METHIONINE; HEART; ISCHEMIC PRECONDITIONING; MALE; MODELS, CARDIOVASCULAR; MORPHINE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NALOXONE; RABBITS; RATS; RECEPTORS, OPIOID, DELTA;

EID: 0033256817     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.6.h2442     Document Type: Article

References (48)

1. Akil, H., C. Owens, H. Gutstein, L. Taylor, E. Curran, and S. Watson. Endogenous opioids: overview and current issues. Drug Alcohol Depend. 51: 127-140, 1998.
2. American Heart Association. 1999 Heart and Stroke Statistical Update. [Online] American Heart Association. http://www. amhrt.org/statistics/index.html [July 1999]
3. Armstrong, S., and C. E. Ganote. Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement. Cardiovasc. Res. 28: 1049-1056, 1994.
4. Armstrong, S. C., and C. E. Ganote. Effects of 2,3-butanedione monoxime (BDM) on contracture and injury of isolated rat myocytes following metabolic inhibition and ischemia. J. Mol. Cell. Cardiol. 23: 1001-1014, 1991.
5. Barron, B. A., H. Gu, J. F. Gaugl, and J. L. Caffrey. Screening for opioids in dog heart. J. Mol. Cell. Cardiol. 24: 67-77, 1992.
6. Barron, B. A., L. X. Oakford, J. F. Gaugl, and J. L. Caffrey. Methionine-enkephalin-Arg-Phe immunoreactivity in heart tissue. Peptides 16: 1221-1227, 1995.
7. Bausback, H. H., and P. E. Ward. Degradation of low-molecular-weight opioid peptides by vascular plasma membrane aminopeptidase M. Biochim. Biophys. Acta 882: 437-444, 1986.
8. Bolling, S. F., T.-P. Su, K. F. Childs, X.-H. Ning, N. Horton, K. Kilgore, and P. R. Oeltgen. The use of hibernation induction triggers for cardiac transplant preservation. Transplantation 63: 326-329, 1997.
9. Borsodi, A., and G. Toth. Characterization of opioid receptor types and subtypes with new ligands. Ann. NY Acad. Sci. 265: 339-352, 1995
10. Chien, G. L., K. Mohtadi, R. A. Wolff, and D. M. Van Winkle. Naloxone blockade of myocardial ischemic preconditioning does not require central nervous system participation. Basic Res. Cardiol. 94: 136-143, 1999.
11. Chien, G. L., and D. M. Van Winkle. Naloxone blockade of myocardial ischaemic preconditioning is stereoselective. J. Mol. Cell. Cardiol. 28: 1895-1900, 1996.
12. Dores, R. M., H. Akil, and S. J. Watson. Strategies for studying opioid peptide regulation at the gene, message and protein levels. Peptides 5, Suppl. 1: 9-17, 1984.
13. Forman, L. H., and O. Bagasra. Demonstration by in situ hybridization of the proopiomelanocortin gene in the rat heart. Brain Res. Bull. 28: 441-445, 1992.
14. Holaday, J. W. Cardiovascular effects of endogenous opiate systems. Annu. Rev. Pharmacol. Toxicol. 23: 541-594, 1983.
15. Howells, R. D., D. L. Kilpatrick, L. C. Bailey, M. Noe, and S. Udenfriend. Proenkephalin mRNA in rat heart. Proc. Natl. Acad. Sci. USA 83:1960-1963, 1986.
16. Kevelaitis, E., J. Peynet, C. Mouas, J.-M. Launay, and P. Menasché. Opening of potassium channels. The common cardioprotective link between preconditioning and natural hibernation? Circulation 99: 3079-3085, 1999.
17. Kindman, L. A., R. E. Kates, and R. Ginsburg. Opioids potentiate contractile response of rabbit myocardium to the beta adrenergic agonist isoproterenol. J. Cardiovasc. Pharmacol. 17: 61-67, 1991.
18. Lee, A. Y. S., C. Y. Zhan, and T. M. Wong. Effects of β-endorphin on the contraction and electrical activity of the isolated perfused rat heart. Int. J. Pept. Protein Res. 24: 525-528, 1984.
19. ATP channels. Circ. Res. 84: 1396-1400, 1999.
20. Llorens-Cortes, C., H. Huang, P. Vicart, J.-M. Gasc, D. Paulin, and P. Corvol. Identification and characterization of neutral endopeptidase in endothelial cells from venous or arterial origins. J. Biol. Chem. 267: 14012-14018, 1992.
21. Lou, L. G., and G. Pei. Modulation of protein kinase C and cAMP-dependent protein kinase by delta-opioid. Biochem. Biophys. Res. Commun. 236: 626-629, 1997.
22. +-ATPase activity by dynorphin-A and ethylketocyclazocine. Life Sci. 42: 461-468, 1988.
23. Maslov, L. N., and Y. B. Lishmanov. Change in opioid peptide level in the heart and blood plasma during acute myocardial ischaemia complicated by ventricular fibrillation. Clin. Exp. Pharmacol. Physiol. 22: 812-816, 1995.
24. Mild, T., M. V. Cohen, and J. M. Downey. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol. Cell. Biochem. 186: 3-12, 1998.
25. Millington, W. R., V. R. Evans, C. N. Battie, O. Bagasra, and L. H. Forman. Proopiomelanocortin-derived peptides and mRNA are expressed in rat heart. Ann. NY Acad. Sci. 680: 575-578, 1993.
26. Millington, W. R., V. R. Evans, L. J. Forman, and C. N. Battie. Characterization of β-endorphin and α-MSH related peptides in rat heart. Peptides 14: 1141-1147, 1993.
27. Minami, M., and M. Satoh. Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci. Res 23: 121-145, 1995.
28. Mulder, A. H., G. Wardeh, F. Hogenboom, and A. L. Frankhuyzen. Selectivity of various opioid peptides toward delta-, kappa-, and mu-opioid receptors mediating presynaptic inhibition of transmitter release in the brain. Neuropeptides 14: 99-104, 1989.
29. 7 by inhibiting its degradation in mouse brain. Mol. Pharmacol. 28: 521-526, 1985.
30. Ogutman, C., I. Kaputlu, and G. Sadan. Cardiovascular effects of intrathecally injected mu, delta and kappa opioid receptor agonists in rabbits. J. Auton. Pharmacol. 15: 443-450, 1995.
31. Reisine, R., and G. I. Bell. Molecular biology of opioid receptors. Trends Neurosci. 16: 506-510, 1993.
32. Rubinstein, M., J. S. Mogil, M. Japon, E. C. Chan, R. G. Allen, and M. J. Low. Absence of opioid stress-induced analgesia in mice lacking β-endorphin by site-directed mutagenesis. Proc. Natl. Acad. Sci. USA 93: 3995-4000, 1996.
33. Sanchez-Blazquez, P., J. K. Chang, J. Garzon, and N. M. Lee. Dynorphin B-29: chemical synthesis and pharmacological properties in opioid systems in vitro. Neuropeptides 4: 369-374, 1984.
34. Schultz, J. E. J., A. K. Hsu, and G. J. Gross. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in rat heart. Circ. Res. 78: 1100-1104, 1996.
35. Schultz, J. E. J., A. K. Hsu, and G. J. Gross. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (8)-opioid receptor in the intact rat heart. J. Mol. Cell. Cardiol. 29: 2187-2195, 1997.
36. 1-but not μ-or κ-opioid receptors. Circulation 97: 1282-1289, 1998.
37. ATP channels. Am. J. Physiol. 274 (Heart Circ. Physiol. 43): H909-H914, 1998.
38. Schultz, J. E. J., E. Rose, Z. Yao, and G. J. Gross. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H2157-H2161, 1995.
39. Schwartz, J.-C. Biological inactivation of enkephalins and the role of enkephalin-dipeptidyl-carboxypeptidase ("enkephalinase") as neuropeptidase. Life Sci. 29: 1715-1740, 1981.
40. Springhorn, J. P., and W. C. Claycomb. Translation of heart preproenkephalin mRNA and secretion of enkephalin peptides from cultured cardiac myocytes. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1560-H1566, 1992.
41. Tomai, F., P. Crea, A. Gaspardone, F. Versaci, A. S. Ghini, C. Ferri, G. Desideri, L. Chiariello, and P. A. Gioffré. Evidence of naloxone on myocardial ischemic preconditioning in humans. J. Am. Coll. Cardiol. 33: 1863-1869, 1999.
42. Tsuchida, A., T. Miura, M. Tanno, Y. Nozawa, H. Kita, and K. Shimamoto. Time window for the contribution of the δ-opioid receptor to cardioprotection by ischemic preconditioning in the rat heart. Cardiovasc. Drugs Ther. 12: 365-373, 1998.
43. Van Winkle, D. M., D. L. Miller, and M. J. Low. β-Endorphin knock-out mice exhibit myocardial ischemic preconditioning (Abstract). Circulation 98: I-416, 1998.
44. Ventura, C., C. Guarnieri, I. Vaona, G. Campana, G. Pintus, and S. Spampinato. Dynorphin gene expression and release in the myocardial cell. J. Biol. Chem. 269: 5384-5386, 1994.
45. Wang, T.-L., H. Chang, C.-R. Hung, and Y.-Z. Tseng. Morphine preconditioning attenuates neutrophil activation in rat models of myocardial infarction. Cardiovasc. Res. 40: 557-563, 1998.
46. Weinbrenner, C., C. P. Baines, G. S. Liu, C. E. Ganote, A. H. Walsh, R. E. Honkanen, M. V. Cohen, and J. M. Downey. Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after onset of ischemia. Circulation 98: 899-905, 1998.
47. Wu, S., H. Y. Li, and T. M. Wong. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of κ-opioid receptor. Circ. Res. 84: 1388-1395, 1999.
48. Zimlichman, R., D. Gefel, H. Eliahou, Z. Matas, B. Rosen, S. Gass, C. Ela, Y. Eilam, Z. Vogel, and J. Barg. Expression of opioid receptors during heart ontogeny in normotensive and hypertensive rats. Circulation 93: 1020-1025, 1996.